Oculis Holding AG (OCS) Liabilities and Shareholders Equity (2021 - 2026)

Oculis Holding AG (OCS) recorded quarterly Liabilities and Shareholders Equity of $311.6 million in Q1 2026, up 5.54% quarter-over-quarter from $295.2 million in Q4 2025, and up 37.21% on a YoY basis from $227.1 million in Q1 2025.

Oculis Holding AG (OCS) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Oculis Holding AG's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $311.6 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 37.21% year-over-year to $311.6 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 56.29% YoY), while the FY2025 annual figure was $295.2 million, up 114.89% from the prior year.
  • Liabilities and Shareholders Equity was $311.6 million for Q1 2026 at Oculis Holding AG, up from $295.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $311.6 million in Q1 2026 to a low of $38.5 million in Q4 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $175.0 million across 5 years, with a median of $150.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity sank 38.89% in 2022, then jumped 235.12% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $38.5 million in 2022, then surged by 235.12% to $128.9 million in 2023, then increased by 6.57% to $137.4 million in 2024, then surged by 114.89% to $295.2 million in 2025, then climbed by 5.54% to $311.6 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $311.6 million (Q1 2026), $295.2 million (Q4 2025), and $209.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 37.37 Mn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 14.93 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 1.73 Bn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 33.89 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 23.64 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 26.48 Bn
9 Abivax 90.15 Bn 90.15 Bn - 640.56 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 311.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 311.58 Mn
Dec 31, 2025 295.23 Mn
Sep 30, 2025 209.81 Mn
Jun 30, 2025 219.38 Mn
Mar 31, 2025 227.09 Mn
Dec 31, 2024 137.39 Mn
Sep 30, 2024 144.98 Mn
Jun 30, 2024 153.41 Mn
Mar 31, 2024 113.09 Mn
Dec 31, 2023 128.92 Mn
Sep 30, 2023 145.98 Mn
Jun 30, 2023 149.97 Mn
Dec 31, 2022 38.47 Mn
Dec 31, 2021 62.95 Mn